6 drugmakers referred to HHS inspector general for denying 340B discounts

(By Maia Anderson for Becker’s Hospital Review)

The HHS Health Resources & Services Administration sent letters to six drugmakers Sept. 22 warning that they may face monetary penalties of $5,000 each for refusing to give 340B discounts to covered entities.  Continue reading the article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org